HCPCS J Codes | Complete List (Updated 2024)
Welcome to our in-depth guide on HCPCS J Codes, a vital aspect of medical billing and coding. These codes play a pivotal role in accurately documenting and reimbursing for drugs administered through methods other than oral ingestion, with a particular focus on chemotherapy drugs. This comprehensive guide aims to provide a detailed understanding of HCPCS J-Codes, their significance, and how they are utilized in the healthcare industry. Additionally we discover where these codes applied and list of HCPCS J Codes with detailed descriptions.
HCPCS J Codes
Drugs administered other than oral method, chemotherapy drugs
HCPCS J Codes | HCPCS J-Codes |
---|---|
J0120 | Injection, tetracycline, up to 250 mg |
J0121 | Injection, omadacycline, 1 mg |
J0122 | Injection, eravacycline, 1 mg |
J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
J0130 | Injection abciximab, 10 mg |
J0131 | Injection, acetaminophen, not otherwise specified,10 mg |
J0132 | Injection, acetylcysteine, 100 mg |
J0133 | Injection, acyclovir, 5 mg |
J0134 | Injection, acetaminophen (fresenius kabi) not therapeutically equivalent to j0131, 10 mg |
J0135 | Injection, adalimumab, 20 mg |
J0136 | Injection, acetaminophen (b braun) not therapeutically equivalent to j0131, 10 mg |
J0137 | Injection, acetaminophen (hikma) not therapeutically equivalent to j0131, 10 mg |
J0150 | Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) |
J0151 | Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) |
J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
J0171 | Injection, adrenalin, epinephrine, 0.1 mg |
J0172 | Injection, aducanumab-avwa, 2 mg |
J0173 | Injection, epinephrine (belcher) not therapeutically equivalent to j0171, 0.1 mg |
J0174 | Injection, lecanemab-irmb, 1 mg |
J0178 | Injection, aflibercept, 1 mg |
J0179 | Injection, brolucizumab-dbll, 1 mg |
J0180 | Injection, agalsidase beta, 1 mg |
J0184 | Injection, amisulpride, 1 mg New |
J0185 | Injection, aprepitant, 1 mg |
J0190 | Injection, biperiden lactate, per 5 mg |
J0200 | Injection, alatrofloxacin mesylate, 100 mg |
J0202 | Injection, alemtuzumab, 1 mg |
J0205 | Injection, alglucerase, per 10 units |
J0206 | Injection, allopurinol sodium, 1 mg |
J0207 | Injection, amifostine, 500 mg |
J0208 | Injection, sodium thiosulfate, 100 mg |
J0210 | Injection, methyldopate hcl, up to 250 mg |
J0215 | Injection, alefacept, 0.5 mg |
J0216 | Injection, alfentanil hydrochloride, 500 micrograms |
J0217 | Injection, velmanase alfa-tycv, 1 mg New |
J0218 | Injection, olipudase alfa-rpcp, 1 mg |
J0219 | Injection, avalglucosidase alfa-ngpt, 4 mg |
J0220 | Injection, alglucosidase alfa, 10 mg, not otherwise specified |
J0221 | Injection, alglucosidase alfa, (lumizyme), 10 mg |
J0222 | Injection, patisiran, 0.1 mg |
J0223 | Injection, givosiran, 0.5 mg |
J0224 | Injection, lumasiran, 0.5 mg |
J0225 | Injection, vutrisiran, 1 mg |
J0248 | Injection, remdesivir, 1 mg |
J0256 | Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg |
J0257 | Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg |
J0270 | Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
J0275 | Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
J0278 | Injection, amikacin sulfate, 100 mg |
J0280 | Injection, aminophyllin, up to 250 mg |
J0282 | Injection, amiodarone hydrochloride, 30 mg |
J0283 | Injection, amiodarone hydrochloride (nexterone), 30 mg |
J0285 | Injection, amphotericin b, 50 mg |
J0287 | Injection, amphotericin b lipid complex, 10 mg |
J0288 | Injection, amphotericin b cholesteryl sulfate complex, 10 mg |
J0289 | Injection, amphotericin b liposome, 10 mg |
J0290 | Injection, ampicillin sodium, 500 mg |
J0291 | Injection, plazomicin, 5 mg |
J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
J0300 | Injection, amobarbital, up to 125 mg |
J0330 | Injection, succinylcholine chloride, up to 20 mg |
J0348 | Injection, anidulafungin, 1 mg |
J0349 | Injection, rezafungin, 1 mg |
J0350 | Injection, anistreplase, per 30 units |
J0360 | Injection, hydralazine hcl, up to 20 mg |
J0364 | Injection, apomorphine hydrochloride, 1 mg |
J0365 | Injection, aprotonin, 10,000 kiu |
J0380 | Injection, metaraminol bitartrate, per 10 mg |
J0390 | Injection, chloroquine hydrochloride, up to 250 mg |
J0391 | Injection, artesunate, 1 mg New |
J0395 | Injection, arbutamine hcl, 1 mg |
J0400 | Injection, aripiprazole, intramuscular, 0.25 mg |
J0401 | Injection, aripiprazole, extended release, 1 mg |
J0402 | Injection, aripiprazole (abilify asimtufii), 1 mg New |
J0456 | Injection, azithromycin, 500 mg |
J0457 | Injection, aztreonam, 100 mg |
J0461 | Injection, atropine sulfate, 0.01 mg |
J0470 | Injection, dimercaprol, per 100 mg |
J0475 | Injection, baclofen, 10 mg |
J0476 | Injection, baclofen, 50 mcg for intrathecal trial |
J0480 | Injection, basiliximab, 20 mg |
J0485 | Injection, belatacept, 1 mg |
J0490 | Injection, belimumab, 10 mg |
J0491 | Injection, anifrolumab-fnia, 1 mg |
J0500 | Injection, dicyclomine hcl, up to 20 mg |
J0515 | Injection, benztropine mesylate, per 1 mg |
J0517 | Injection, benralizumab, 1 mg |
J0520 | Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg |
J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units |
J0561 | Injection, penicillin g benzathine, 100,000 units |
J0565 | Injection, bezlotoxumab, 10 mg |
J0567 | Injection, cerliponase alfa, 1 mg |
J0570 | Buprenorphine implant, 74.2 mg |
J0571 | Buprenorphine, oral, 1 mg |
J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine |
J0573 | Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine |
J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
J0575 | Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine |
J0576 | Injection, buprenorphine extended-release (brixadi), 1 mg New |
J0583 | Injection, bivalirudin, 1 mg |
J0584 | Injection, burosumab-twza 1 mg |
J0585 | Injection, onabotulinumtoxina, 1 unit |
J0586 | Injection, abobotulinumtoxina, 5 units |
J0587 | Injection, rimabotulinumtoxinb, 100 units |
J0588 | Injection, incobotulinumtoxin a, 1 unit |
J0591 | Injection, deoxycholic acid, 1 mg |
J0592 | Injection, buprenorphine hydrochloride, 0.1 mg |
J0593 | Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) |
J0594 | Injection, busulfan, 1 mg |
J0595 | Injection, butorphanol tartrate, 1 mg |
J0596 | Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units |
J0597 | Injection, c-1 esterase inhibitor (human), berinert, 10 units |
J0598 | Injection, c-1 esterase inhibitor (human), cinryze, 10 units |
J0599 | Injection, c-1 esterase inhibitor (human), (haegarda), 10 units |
J0600 | Injection, edetate calcium disodium, up to 1000 mg |
J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
J0606 | Injection, etelcalcetide, 0.1 mg |
J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml |
J0611 | Injection, calcium gluconate (wg critical care), per 10 ml |
J0612 | Injection, calcium gluconate (fresenius kabi), per 10 mg |
J0613 | Injection, calcium gluconate (wg critical care), per 10 mg |
J0620 | Injection, calcium glycerophosphate and calcium lactate, per 10 ml |
J0630 | Injection, calcitonin salmon, up to 400 units |
J0636 | Injection, calcitriol, 0.1 mcg |
J0637 | Injection, caspofungin acetate, 5 mg |
J0638 | Injection, canakinumab, 1 mg |
J0640 | Injection, leucovorin calcium, per 50 mg |
J0641 | Injection, levoleucovorin, not otherwise specified, 0.5 mg |
J0642 | Injection, levoleucovorin (khapzory), 0.5 mg |
J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg |
J0670 | Injection, mepivacaine hydrochloride, per 10 ml |
J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg New |
J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
J0690 | Injection, cefazolin sodium, 500 mg |
J0691 | Injection, lefamulin, 1 mg |
J0692 | Injection, cefepime hydrochloride, 500 mg |
J0693 | Injection, cefiderocol, 5 mg |
J0694 | Injection, cefoxitin sodium, 1 gm |
J0695 | Injection, ceftolozane 50 mg and tazobactam 25 mg |
J0696 | Injection, ceftriaxone sodium, per 250 mg |
J0697 | Injection, sterile cefuroxime sodium, per 750 mg |
J0698 | Injection, cefotaxime sodium, per gm |
J0699 | Injection, cefiderocol, 10 mg |
J0701 | Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg |
J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
J0703 | Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg |
J0706 | Injection, caffeine citrate, 5 mg |
J0710 | Injection, cephapirin sodium, up to 1 gm |
J0712 | Injection, ceftaroline fosamil, 10 mg |
J0713 | Injection, ceftazidime, per 500 mg |
J0714 | Injection, ceftazidime and avibactam, 0.5 g/0.125 g |
J0715 | Injection, ceftizoxime sodium, per 500 mg |
J0716 | Injection, centruroides immune f(ab)2, up to 120 milligrams |
J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
J0720 | Injection, chloramphenicol sodium succinate, up to 1 gm |
J0725 | Injection, chorionic gonadotropin, per 1,000 usp units |
J0735 | Injection, clonidine hydrochloride, 1 mg |
J0736 | Injection, clindamycin phosphate, 300 mg |
J0737 | Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
J0739 | Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) |
J0740 | Injection, cidofovir, 375 mg |
J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg |
J0742 | Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg |
J0743 | Injection, cilastatin sodium; imipenem, per 250 mg |
J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg |
J0745 | Injection, codeine phosphate, per 30 mg |
J0750 | Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) New |
J0751 | Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) New |
J0760 | Injection, colchicine, per 1 mg |
J0770 | Injection, colistimethate sodium, up to 150 mg |
J0775 | Injection, collagenase, clostridium histolyticum, 0.01 mg |
J0780 | Injection, prochlorperazine, up to 10 mg |
J0791 | Injection, crizanlizumab-tmca, 5 mg |
J0795 | Injection, corticorelin ovine triflutate, 1 microgram |
J0799 | Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified New |
J0800 | Injection, corticotropin, up to 40 units |
J0801 | Injection, corticotropin (acthar gel), up to 40 units |
J0802 | Injection, corticotropin (ani), up to 40 units |
J0833 | Injection, cosyntropin, not otherwise specified, 0.25 mg |
J0834 | Injection, cosyntropin, 0.25 mg |
J0840 | Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram |
J0841 | Injection, crotalidae immune f(ab’)2 (equine), 120 mg |
J0850 | Injection, cytomegalovirus immune globulin intravenous (human), per vial |
J0873 | Injection, daptomycin (xellia) not therapeutically equivalent to j0878, 1 mg New |
J0874 | Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg |
J0875 | Injection, dalbavancin, 5 mg |
J0877 | Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg |
J0878 | Injection, daptomycin, 1 mg |
J0879 | Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis) |
J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
J0883 | Injection, argatroban, 1 mg (for non-esrd use) |
J0884 | Injection, argatroban, 1 mg (for esrd on dialysis) |
J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units |
J0886 | Injection, epoetin alfa, 1000 units (for esrd on dialysis) |
J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
J0888 | Injection, epoetin beta, 1 microgram, (for non esrd use) |
J0889 | Daprodustat, oral, 1 mg, (for esrd on dialysis) |
J0890 | Injection, peginesatide, 0.1 mg (for esrd on dialysis) |
J0891 | Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) |
J0892 | Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) |
J0893 | Injection, decitabine (sun pharma) not therapeutically equivalent to j0894, 1 mg |
J0894 | Injection, decitabine, 1 mg |
J0895 | Injection, deferoxamine mesylate, 500 mg |
J0896 | Injection, luspatercept-aamt, 0.25 mg |
J0897 | Injection, denosumab, 1 mg |
J0898 | Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) |
J0899 | Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) |
J0900 | Injection, testosterone enanthate and estradiol valerate, up to 1 cc |
J0945 | Injection, brompheniramine maleate, per 10 mg |
J1000 | Injection, depo-estradiol cypionate, up to 5 mg |
J1020 | Injection, methylprednisolone acetate, 20 mg |
J1030 | Injection, methylprednisolone acetate, 40 mg |
J1040 | Injection, methylprednisolone acetate, 80 mg |
J1050 | Injection, medroxyprogesterone acetate, 1 mg |
J1060 | Injection, testosterone cypionate and estradiol cypionate, up to 1 ml |
J1070 | Injection, testosterone cypionate, up to 100 mg |
J1071 | Injection, testosterone cypionate, 1 mg |
J1080 | Injection, testosterone cypionate, 1 cc, 200 mg |
J1094 | Injection, dexamethasone acetate, 1 mg |
J1095 | Injection, dexamethasone 9 percent, intraocular, 1 microgram |
J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg |
J1097 | Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml |
J1100 | Injection, dexamethasone sodium phosphate, 1 mg |
J1105 | Dexmedetomidine, oral, 1 mcg New |
J1110 | Injection, dihydroergotamine mesylate, per 1 mg |
J1120 | Injection, acetazolamide sodium, up to 500 mg |
J1130 | Injection, diclofenac sodium, 0.5 mg |
J1160 | Injection, digoxin, up to 0.5 mg |
J1162 | Injection, digoxin immune fab (ovine), per vial |
J1165 | Injection, phenytoin sodium, per 50 mg |
J1170 | Injection, hydromorphone, up to 4 mg |
J1180 | Injection, dyphylline, up to 500 mg |
J1190 | Injection, dexrazoxane hydrochloride, per 250 mg |
J1200 | Injection, diphenhydramine hcl, up to 50 mg |
J1201 | Injection, cetirizine hydrochloride, 0.5 mg |
J1205 | Injection, chlorothiazide sodium, per 500 mg |
J1212 | Injection, dmso, dimethyl sulfoxide, 50%, 50 ml |
J1230 | Injection, methadone hcl, up to 10 mg |
J1240 | Injection, dimenhydrinate, up to 50 mg |
J1245 | Injection, dipyridamole, per 10 mg |
J1250 | Injection, dobutamine hydrochloride, per 250 mg |
J1260 | Injection, dolasetron mesylate, 10 mg |
J1265 | Injection, dopamine hcl, 40 mg |
J1267 | Injection, doripenem, 10 mg |
J1270 | Injection, doxercalciferol, 1 mcg |
J1290 | Injection, ecallantide, 1 mg |
J1300 | Injection, eculizumab, 10 mg |
J1301 | Injection, edaravone, 1 mg |
J1302 | Injection, sutimlimab-jome, 10 mg |
J1303 | Injection, ravulizumab-cwvz, 10 mg |
J1304 | Injection, tofersen, 1 mg New |
J1305 | Injection, evinacumab-dgnb, 5mg |
J1306 | Injection, inclisiran, 1 mg |
J1320 | Injection, amitriptyline hcl, up to 20 mg |
J1322 | Injection, elosulfase alfa, 1 mg |
J1324 | Injection, enfuvirtide, 1 mg |
J1325 | Injection, epoprostenol, 0.5 mg |
J1327 | Injection, eptifibatide, 5 mg |
J1330 | Injection, ergonovine maleate, up to 0.2 mg |
J1335 | Injection, ertapenem sodium, 500 mg |
J1364 | Injection, erythromycin lactobionate, per 500 mg |
J1380 | Injection, estradiol valerate, up to 10 mg |
J1410 | Injection, estrogen conjugated, per 25 mg |
J1411 | Injection, etranacogene dezaparvovec-drlb, per therapeutic dose |
J1412 | Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes New |
J1413 | Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose New |
J1426 | Injection, casimersen, 10 mg |
J1427 | Injection, viltolarsen, 10 mg |
J1428 | Injection, eteplirsen, 10 mg |
J1429 | Injection, golodirsen, 10 mg |
J1430 | Injection, ethanolamine oleate, 100 mg |
J1435 | Injection, estrone, per 1 mg |
J1436 | Injection, etidronate disodium, per 300 mg |
J1437 | Injection, ferric derisomaltose, 10 mg |
J1438 | Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
J1439 | Injection, ferric carboxymaltose, 1 mg |
J1440 | Fecal microbiota, live – jslm, 1 ml |
J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram |
J1443 | Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron |
J1444 | Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron |
J1445 | Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron |
J1446 | Injection, tbo-filgrastim, 5 micrograms |
J1447 | Injection, tbo-filgrastim, 1 microgram |
J1448 | Injection, trilaciclib, 1mg |
J1449 | Injection, eflapegrastim-xnst, 0.1 mg |
J1450 | Injection fluconazole, 200 mg |
J1451 | Injection, fomepizole, 15 mg |
J1452 | Injection, fomivirsen sodium, intraocular, 1.65 mg |
J1453 | Injection, fosaprepitant, 1 mg |
J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg |
J1455 | Injection, foscarnet sodium, per 1000 mg |
J1456 | Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg |
J1457 | Injection, gallium nitrate, 1 mg |
J1458 | Injection, galsulfase, 1 mg |
J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
J1460 | Injection, gamma globulin, intramuscular, 1 cc |
J1551 | Injection, immune globulin (cutaquig), 100 mg |
J1554 | Injection, immune globulin (asceniv), 500 mg |
J1555 | Injection, immune globulin (cuvitru), 100 mg |
J1556 | Injection, immune globulin (bivigam), 500 mg |
J1557 | Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg |
J1558 | Injection, immune globulin (xembify), 100 mg |
J1559 | Injection, immune globulin (hizentra), 100 mg |
J1560 | Injection, gamma globulin, intramuscular, over 10 cc |
J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
J1562 | Injection, immune globulin (vivaglobin), 100 mg |
J1566 | Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg |
J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg |
J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
J1570 | Injection, ganciclovir sodium, 500 mg |
J1571 | Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml |
J1572 | Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg |
J1573 | Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml |
J1574 | Injection, ganciclovir sodium (exela) not therapeutically equivalent to j1570, 500 mg |
J1575 | Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin |
J1576 | Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg |
J1580 | Injection, garamycin, gentamicin, up to 80 mg |
J1590 | Injection, gatifloxacin, 10 mg |
J1595 | Injection, glatiramer acetate, 20 mg |
J1596 | Injection, glycopyrrolate, 0.1 mg New |
J1599 | Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg |
J1600 | Injection, gold sodium thiomalate, up to 50 mg |
J1602 | Injection, golimumab, 1 mg, for intravenous use |
J1610 | Injection, glucagon hydrochloride, per 1 mg |
J1611 | Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg |
J1620 | Injection, gonadorelin hydrochloride, per 100 mcg |
J1626 | Injection, granisetron hydrochloride, 100 mcg |
J1627 | Injection, granisetron, extended-release, 0.1 mg |
J1628 | Injection, guselkumab, 1 mg |
J1630 | Injection, haloperidol, up to 5 mg |
J1631 | Injection, haloperidol decanoate, per 50 mg |
J1632 | Injection, brexanolone, 1 mg |
J1640 | Injection, hemin, 1 mg |
J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units |
J1643 | Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
J1644 | Injection, heparin sodium, per 1000 units |
J1645 | Injection, dalteparin sodium, per 2500 iu |
J1650 | Injection, enoxaparin sodium, 10 mg |
J1652 | Injection, fondaparinux sodium, 0.5 mg |
J1655 | Injection, tinzaparin sodium, 1000 iu |
J1670 | Injection, tetanus immune globulin, human, up to 250 units |
J1675 | Injection, histrelin acetate, 10 micrograms |
J1700 | Injection, hydrocortisone acetate, up to 25 mg |
J1710 | Injection, hydrocortisone sodium phosphate, up to 50 mg |
J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg |
J1725 | Injection, hydroxyprogesterone caproate, 1 mg |
J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg |
J1729 | Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg |
J1730 | Injection, diazoxide, up to 300 mg |
J1738 | Injection, meloxicam, 1 mg |
J1740 | Injection, ibandronate sodium, 1 mg |
J1741 | Injection, ibuprofen, 100 mg |
J1742 | Injection, ibutilide fumarate, 1 mg |
J1743 | Injection, idursulfase, 1 mg |
J1744 | Injection, icatibant, 1 mg |
J1745 | Injection, infliximab, excludes biosimilar, 10 mg |
J1746 | Injection, ibalizumab-uiyk, 10 mg |
J1747 | Injection, spesolimab-sbzo, 1 mg |
J1750 | Injection, iron dextran, 50 mg |
J1756 | Injection, iron sucrose, 1 mg |
J1786 | Injection, imiglucerase, 10 units |
J1790 | Injection, droperidol, up to 5 mg |
J1800 | Injection, propranolol hcl, up to 1 mg |
J1805 | Injection, esmolol hydrochloride, 10 mg |
J1806 | Injection, esmolol hydrochloride (wg critical care) not therapeutically equivalent to j1805, 10 mg |
J1810 | Injection, droperidol and fentanyl citrate, up to 2 ml ampule |
J1811 | Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units |
J1812 | Insulin (fiasp), per 5 units |
J1813 | Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units |
J1814 | Insulin (lyumjev), per 5 units |
J1815 | Injection, insulin, per 5 units |
J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units |
J1823 | Injection, inebilizumab-cdon, 1 mg |
J1826 | Injection, interferon beta-1a, 30 mcg |
J1830 | Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
J1833 | Injection, isavuconazonium, 1 mg |
J1835 | Injection, itraconazole, 50 mg |
J1836 | Injection, metronidazole, 10 mg |
J1840 | Injection, kanamycin sulfate, up to 500 mg |
J1850 | Injection, kanamycin sulfate, up to 75 mg |
J1885 | Injection, ketorolac tromethamine, per 15 mg |
J1890 | Injection, cephalothin sodium, up to 1 gram |
J1920 | Injection, labetalol hydrochloride, 5 mg |
J1921 | Injection, labetalol hydrochloride (hikma) not therapeutically equivalent to j1920, 5 mg |
J1930 | Injection, lanreotide, 1 mg |
J1931 | Injection, laronidase, 0.1 mg |
J1932 | Injection, lanreotide, (cipla), 1 mg |
J1939 | Injection, bumetanide, 0.5 mg New |
J1940 | Injection, furosemide, up to 20 mg |
J1941 | Injection, furosemide (furoscix), 20 mg |
J1942 | Injection, aripiprazole lauroxil, 1 mg |
J1943 | Injection, aripiprazole lauroxil, (aristada initio), 1 mg |
J1944 | Injection, aripiprazole lauroxil, (aristada), 1 mg |
J1945 | Injection, lepirudin, 50 mg |
J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
J1951 | Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg |
J1952 | Leuprolide injectable, camcevi, 1 mg |
J1953 | Injection, levetiracetam, 10 mg |
J1954 | Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg |
J1955 | Injection, levocarnitine, per 1 gm |
J1956 | Injection, levofloxacin, 250 mg |
J1960 | Injection, levorphanol tartrate, up to 2 mg |
J1961 | Injection, lenacapavir, 1 mg |
J1980 | Injection, hyoscyamine sulfate, up to 0.25 mg |
J1990 | Injection, chlordiazepoxide hcl, up to 100 mg |
J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg |
J2010 | Injection, lincomycin hcl, up to 300 mg |
J2020 | Injection, linezolid, 200 mg |
J2021 | Injection, linezolid (hospira) not therapeutically equivalent to j2020, 200 mg |
J2060 | Injection, lorazepam, 2 mg |
J2062 | Loxapine for inhalation, 1 mg |
J2150 | Injection, mannitol, 25% in 50 ml |
J2170 | Injection, mecasermin, 1 mg |
J2175 | Injection, meperidine hydrochloride, per 100 mg |
J2180 | Injection, meperidine and promethazine hcl, up to 50 mg |
J2182 | Injection, mepolizumab, 1 mg |
J2184 | Injection, meropenem (b. braun) not therapeutically equivalent to j2185, 100 mg |
J2185 | Injection, meropenem, 100 mg |
J2186 | Injection, meropenem and vaborbactam, 10mg/10mg (20mg) |
J2210 | Injection, methylergonovine maleate, up to 0.2 mg |
J2212 | Injection, methylnaltrexone, 0.1 mg |
J2247 | Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg |
J2248 | Injection, micafungin sodium, 1 mg |
J2249 | Injection, remimazolam, 1 mg |
J2250 | Injection, midazolam hydrochloride, per 1 mg |
J2251 | Injection, midazolam hydrochloride (wg critical care) not therapeutically equivalent to j2250, per 1 mg |
J2260 | Injection, milrinone lactate, 5 mg |
J2265 | Injection, minocycline hydrochloride, 1 mg |
J2270 | Injection, morphine sulfate, up to 10 mg |
J2271 | Injection, morphine sulfate, 100mg |
J2272 | Injection, morphine sulfate (fresenius kabi) not therapeutically equivalent to j2270, up to 10 mg |
J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
J2275 | Injection, morphine sulfate (preservative-free sterile solution), per 10 mg |
J2278 | Injection, ziconotide, 1 microgram |
J2280 | Injection, moxifloxacin, 100 mg |
J2281 | Injection, moxifloxacin (fresenius kabi) not therapeutically equivalent to j2280, 100 mg |
J2300 | Injection, nalbuphine hydrochloride, per 10 mg |
J2305 | Injection, nitroglycerin, 5 mg |
J2310 | Injection, naloxone hydrochloride, per 1 mg |
J2311 | Injection, naloxone hydrochloride (zimhi), 1 mg |
J2315 | Injection, naltrexone, depot form, 1 mg |
J2320 | Injection, nandrolone decanoate, up to 50 mg |
J2323 | Injection, natalizumab, 1 mg |
J2325 | Injection, nesiritide, 0.1 mg |
J2326 | Injection, nusinersen, 0.1 mg |
J2327 | Injection, risankizumab-rzaa, intravenous, 1 mg |
J2329 | Injection, ublituximab-xiiy, 1mg |
J2350 | Injection, ocrelizumab, 1 mg |
J2353 | Injection, octreotide, depot form for intramuscular Injection, 1 mg |
J2354 | Injection, octreotide, non-depot form for subcutaneous or intravenous Injection, 25 mcg |
J2355 | Injection, oprelvekin, 5 mg |
J2356 | Injection, tezepelumab-ekko, 1 mg |
J2357 | Injection, omalizumab, 5 mg |
J2358 | Injection, olanzapine, long-acting, 1 mg |
J2359 | Injection, olanzapine, 0.5 mg |
J2360 | Injection, orphenadrine citrate, up to 60 mg |
J2370 | Injection, phenylephrine hcl, up to 1 ml |
J2371 | Injection, phenylephrine hydrochloride, 20 micrograms |
J2372 | Injection, phenylephrine hydrochloride (biorphen), 20 micrograms |
J2400 | Injection, chloroprocaine hydrochloride, per 30 ml |
J2401 | Injection, chloroprocaine hydrochloride, per 1 mg |
J2402 | Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg |
J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg |
J2404 | Injection, nicardipine, 0.1 mg New |
J2405 | Injection, ondansetron hydrochloride, per 1 mg |
J2406 | Injection, oritavancin (kimyrsa), 10 mg |
J2407 | Injection, oritavancin (orbactiv), 10 mg |
J2410 | Injection, oxymorphone hcl, up to 1 mg |
J2425 | Injection, palifermin, 50 micrograms |
J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
J2427 | Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg |
J2430 | Injection, pamidronate disodium, per 30 mg |
J2440 | Injection, papaverine hcl, up to 60 mg |
J2460 | Injection, oxytetracycline hcl, up to 50 mg |
J2469 | Injection, palonosetron hcl, 25 mcg |
J2501 | Injection, paricalcitol, 1 mcg |
J2502 | Injection, pasireotide long acting, 1 mg |
J2503 | Injection, pegaptanib sodium, 0.3 mg |
J2504 | Injection, pegademase bovine, 25 iu |
J2505 | Injection, pegfilgrastim, 6 mg |
J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
J2507 | Injection, pegloticase, 1 mg |
J2508 | Injection, pegunigalsidase alfa-iwxj, 1 mg New |
J2510 | Injection, penicillin g procaine, aqueous, up to 600,000 units |
J2513 | Injection, pentastarch, 10% solution, 100 ml |
J2515 | Injection, pentobarbital sodium, per 50 mg |
J2540 | Injection, penicillin g potassium, up to 600,000 units |
J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
J2545 | Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg |
J2547 | Injection, peramivir, 1 mg |
J2550 | Injection, promethazine hcl, up to 50 mg |
J2560 | Injection, phenobarbital sodium, up to 120 mg |
J2561 | Injection, phenobarbital sodium (sezaby), 1 mg |
J2562 | Injection, plerixafor, 1 mg |
J2590 | Injection, oxytocin, up to 10 units |
J2597 | Injection, desmopressin acetate, per 1 mcg |
J2598 | Injection, vasopressin, 1 unit |
J2599 | Injection, vasopressin (american regent) not therapeutically equivalent to j2598, 1 unit |
J2650 | Injection, prednisolone acetate, up to 1 ml |
J2670 | Injection, tolazoline hcl, up to 25 mg |
J2675 | Injection, progesterone, per 50 mg |
J2679 | Injection, fluphenazine hcl, 1.25 mg New |
J2680 | Injection, fluphenazine decanoate, up to 25 mg |
J2690 | Injection, procainamide hcl, up to 1 gm |
J2700 | Injection, oxacillin sodium, up to 250 mg |
J2704 | Injection, propofol, 10 mg |
J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg |
J2720 | Injection, protamine sulfate, per 10 mg |
J2724 | Injection, protein c concentrate, intravenous, human, 10 iu |
J2725 | Injection, protirelin, per 250 mcg |
J2730 | Injection, pralidoxime chloride, up to 1 gm |
J2760 | Injection, phentolamine mesylate, up to 5 mg |
J2765 | Injection, metoclopramide hcl, up to 10 mg |
J2770 | Injection, quinupristin/dalfopristin, 500 mg (150/350) |
J2777 | Injection, faricimab-svoa, 0.1 mg |
J2778 | Injection, ranibizumab, 0.1 mg |
J2779 | Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg |
J2780 | Injection, ranitidine hydrochloride, 25 mg |
J2781 | Injection, pegcetacoplan, intravitreal, 1 mg |
J2783 | Injection, rasburicase, 0.5 mg |
J2785 | Injection, regadenoson, 0.1 mg |
J2786 | Injection, reslizumab, 1 mg |
J2787 | Riboflavin 5′-phosphate, ophthalmic solution, up to 3 ml |
J2788 | Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) |
J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu |
J2792 | Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu |
J2793 | Injection, rilonacept, 1 mg |
J2794 | Injection, risperidone (risperdal consta), 0.5 mg |
J2795 | Injection, ropivacaine hydrochloride, 1 mg |
J2796 | Injection, romiplostim, 10 micrograms |
J2797 | Injection, rolapitant, 0.5 mg |
J2798 | Injection, risperidone, (perseris), 0.5 mg |
J2799 | Injection, risperidone (uzedy), 1 mg New |
J2800 | Injection, methocarbamol, up to 10 ml |
J2805 | Injection, sincalide, 5 micrograms |
J2806 | Injection, sincalide (maia) not therapeutically equivalent to j2805, 5 micrograms |
J2810 | Injection, theophylline, per 40 mg |
J2820 | Injection, sargramostim (gm-csf), 50 mcg |
J2840 | Injection, sebelipase alfa, 1 mg |
J2850 | Injection, secretin, synthetic, human, 1 microgram |
J2860 | Injection, siltuximab, 10 mg |
J2910 | Injection, aurothioglucose, up to 50 mg |
J2916 | Injection, sodium ferric gluconate complex in sucrose Injection, 12.5 mg |
J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg |
J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg |
J2940 | Injection, somatrem, 1 mg |
J2941 | Injection, somatropin, 1 mg |
J2950 | Injection, promazine hcl, up to 25 mg |
J2993 | Injection, reteplase, 18.1 mg |
J2995 | Injection, streptokinase, per 250,000 iu |
J2997 | Injection, alteplase recombinant, 1 mg |
J2998 | Injection, plasminogen, human-tvmh, 1 mg |
J3000 | Injection, streptomycin, up to 1 gm |
J3010 | Injection, fentanyl citrate, 0.1 mg |
J3030 | Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) |
J3031 | Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) |
J3032 | Injection, eptinezumab-jjmr, 1 mg |
J3060 | Injection, taliglucerase alfa, 10 units |
J3070 | Injection, pentazocine, 30 mg |
J3090 | Injection, tedizolid phosphate, 1 mg |
J3095 | Injection, telavancin, 10 mg |
J3101 | Injection, tenecteplase, 1 mg |
J3105 | Injection, terbutaline sulfate, up to 1 mg |
J3110 | Injection, teriparatide, 10 mcg |
J3111 | Injection, romosozumab-aqqg, 1 mg |
J3120 | Injection, testosterone enanthate, up to 100 mg |
J3121 | Injection, testosterone enanthate, 1 mg |
J3130 | Injection, testosterone enanthate, up to 200 mg |
J3140 | Injection, testosterone suspension, up to 50 mg |
J3145 | Injection, testosterone undecanoate, 1 mg |
J3150 | Injection, testosterone propionate, up to 100 mg |
J3230 | Injection, chlorpromazine hcl, up to 50 mg |
J3240 | Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial |
J3241 | Injection, teprotumumab-trbw, 10 mg |
J3243 | Injection, tigecycline, 1 mg |
J3244 | Injection, tigecycline (accord) not therapeutically equivalent to j3243, 1 mg |
J3245 | Injection, tildrakizumab, 1 mg |
J3246 | Injection, tirofiban hcl, 0.25 mg |
J3250 | Injection, trimethobenzamide hcl, up to 200 mg |
J3260 | Injection, tobramycin sulfate, up to 80 mg |
J3262 | Injection, tocilizumab, 1 mg |
J3265 | Injection, torsemide, 10 mg/ml |
J3280 | Injection, thiethylperazine maleate, up to 10 mg |
J3285 | Injection, treprostinil, 1 mg |
J3299 | Injection, triamcinolone acetonide (xipere), 1 mg |
J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg |
J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
J3302 | Injection, triamcinolone diacetate, per 5 mg |
J3303 | Injection, triamcinolone hexacetonide, per 5 mg |
J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
J3305 | Injection, trimetrexate glucuronate, per 25 mg |
J3310 | Injection, perphenazine, up to 5 mg |
J3315 | Injection, triptorelin pamoate, 3.75 mg |
J3316 | Injection, triptorelin, extended-release, 3.75 mg |
J3320 | Injection, spectinomycin dihydrochloride, up to 2 gm |
J3350 | Injection, urea, up to 40 gm |
J3355 | Injection, urofollitropin, 75 iu |
J3357 | Ustekinumab, for subcutaneous Injection, 1 mg |
J3358 | Ustekinumab, for intravenous Injection, 1 mg |
J3360 | Injection, diazepam, up to 5 mg |
J3364 | Injection, urokinase, 5000 iu vial |
J3365 | Injection, iv, urokinase, 250,000 i.u. vial |
J3370 | Injection, vancomycin hcl, 500 mg |
J3371 | Injection, vancomycin hcl (mylan) not therapeutically equivalent to j3370, 500 mg |
J3372 | Injection, vancomycin hcl (xellia) not therapeutically equivalent to j3370, 500 mg |
J3380 | Injection, vedolizumab, 1 mg |
J3385 | Injection, velaglucerase alfa, 100 units |
J3396 | Injection, verteporfin, 0.1 mg |
J3397 | Injection, vestronidase alfa-vjbk, 1 mg |
J3398 | Injection, voretigene neparvovec-rzyl, 1 billion vector genomes |
J3399 | Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5×10^15 vector genomes |
J3400 | Injection, triflupromazine hcl, up to 20 mg |
J3401 | Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml New |
J3410 | Injection, hydroxyzine hcl, up to 25 mg |
J3411 | Injection, thiamine hcl, 100 mg |
J3415 | Injection, pyridoxine hcl, 100 mg |
J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
J3425 | Injection, hydroxocobalamin, 10 mcg New |
J3430 | Injection, phytonadione (vitamin k), per 1 mg |
J3465 | Injection, voriconazole, 10 mg |
J3470 | Injection, hyaluronidase, up to 150 units |
J3471 | Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
J3472 | Injection, hyaluronidase, ovine, preservative free, per 1000 usp units |
J3473 | Injection, hyaluronidase, recombinant, 1 usp unit |
J3475 | Injection, magnesium sulfate, per 500 mg |
J3480 | Injection, potassium chloride, per 2 meq |
J3485 | Injection, zidovudine, 10 mg |
J3486 | Injection, ziprasidone mesylate, 10 mg |
J3489 | Injection, zoledronic acid, 1 mg |
J3490 | Unclassified drugs |
J3520 | Edetate disodium, per 150 mg |
J3530 | Nasal vaccine inhalation |
J3535 | Drug administered through a metered dose inhaler |
J3570 | Laetrile, amygdalin, vitamin b17 |
J3590 | Unclassified biologics |
J3591 | Unclassified drug or biological used for esrd on dialysis |
J7030 | Infusion, normal saline solution , 1000 cc |
J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) |
J7042 | 5% dextrose/normal saline (500 ml = 1 unit) |
J7050 | Infusion, normal saline solution, 250 cc |
J7060 | 5% dextrose/water (500 ml = 1 unit) |
J7070 | Infusion, d5w, 1000 cc |
J7100 | Infusion, dextran 40, 500 ml |
J7110 | Infusion, dextran 75, 500 ml |
J7120 | Ringers lactate infusion, up to 1000 cc |
J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc |
J7131 | Hypertonic saline solution, 1 ml |
J7168 | Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity |
J7169 | Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg |
J7170 | Injection, emicizumab-kxwh, 0.5 mg |
J7175 | Injection, factor x, (human), 1 i.u. |
J7177 | Injection, human fibrinogen concentrate (fibryga), 1 mg |
J7178 | Injection, human fibrinogen concentrate, not otherwise specified, 1 mg |
J7179 | Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco |
J7180 | Injection, factor xiii (antihemophilic factor, human), 1 i.u. |
J7181 | Injection, factor xiii a-subunit, (recombinant), per iu |
J7182 | Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu |
J7183 | Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco |
J7185 | Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. |
J7186 | Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u. |
J7187 | Injection, von willebrand factor complex (humate-p), per iu vwf:rco |
J7188 | Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. |
J7189 | Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram |
J7190 | Factor viii (antihemophilic factor, human) per i.u. |
J7191 | Factor viii (antihemophilic factor (porcine)), per i.u. |
J7192 | Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified |
J7193 | Factor ix (antihemophilic factor, purified, non-recombinant) per i.u. |
J7194 | Factor ix, complex, per i.u. |
J7195 | Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified |
J7196 | Injection, antithrombin recombinant, 50 i.u. |
J7197 | Antithrombin iii (human), per i.u. |
J7198 | Anti-inhibitor, per i.u. |
J7199 | Hemophilia clotting factor, not otherwise classified |
J7200 | Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu |
J7201 | Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. |
J7202 | Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. |
J7203 | Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu |
J7204 | Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu |
J7205 | Injection, factor viii fc fusion protein (recombinant), per iu |
J7207 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. |
J7208 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u. |
J7209 | Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. |
J7210 | Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. |
J7211 | Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. |
J7212 | Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram |
J7213 | Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. |
J7214 | Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. |
J7294 | Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each |
J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each |
J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg |
J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
J7300 | Intrauterine copper contraceptive |
J7301 | Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg |
J7302 | Levonorgestrel-releasing intrauterine contraceptive system, 52 mg |
J7303 | Contraceptive supply, hormone containing vaginal ring, each |
J7304 | Contraceptive supply, hormone containing patch, each |
J7306 | Levonorgestrel (contraceptive) implant system, including implants and supplies |
J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies |
J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) |
J7309 | Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram |
J7310 | Ganciclovir, 4.5 mg, long-acting implant |
J7311 | Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg |
J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg |
J7313 | Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg |
J7314 | Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg |
J7315 | Mitomycin, ophthalmic, 0.2 mg |
J7316 | Injection, ocriplasmin, 0.125 mg |
J7318 | Hyaluronan or derivative, durolane, for intra-articular Injection, 1 mg |
J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular Injection, 1 mg |
J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular Injection, per dose |
J7322 | Hyaluronan or derivative, hymovis, for intra-articular Injection, 1 mg |
J7323 | Hyaluronan or derivative, euflexxa, for intra-articular Injection, per dose |
J7324 | Hyaluronan or derivative, orthovisc, for intra-articular Injection, per dose |
J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular Injection, 1 mg |
J7326 | Hyaluronan or derivative, gel-one, for intra-articular Injection, per dose |
J7327 | Hyaluronan or derivative, monovisc, for intra-articular Injection, per dose |
J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular Injection, 0.1 mg |
J7329 | Hyaluronan or derivative, trivisc, for intra-articular Injection, 1 mg |
J7330 | Autologous cultured chondrocytes, implant |
J7331 | Hyaluronan or derivative, synojoynt, for intra-articular Injection, 1 mg |
J7332 | Hyaluronan or derivative, triluron, for intra-articular Injection, 1 mg |
J7333 | Hyaluronan or derivative, visco-3, for intra-articular Injection, per dose |
J7335 | Capsaicin 8% patch, per 10 square centimeters |
J7336 | Capsaicin 8% patch, per square centimeter |
J7340 | Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml |
J7342 | Instillation, ciprofloxacin otic suspension, 6 mg |
J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg |
J7351 | Injection, bimatoprost, intracameral implant, 1 microgram |
J7352 | Afamelanotide implant, 1 mg |
J7353 | Anacaulase-bcdb, 8.8% gel, 1 gram |
J7401 | Mometasone furoate sinus implant, 10 micrograms |
J7402 | Mometasone furoate sinus implant, (sinuva), 10 micrograms |
J7500 | Azathioprine, oral, 50 mg |
J7501 | Azathioprine, parenteral, 100 mg |
J7502 | Cyclosporine, oral, 100 mg |
J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg |
J7504 | Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg |
J7505 | Muromonab-cd3, parenteral, 5 mg |
J7506 | Prednisone, oral, per 5 mg |
J7507 | Tacrolimus, immediate release, oral, 1 mg |
J7508 | Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg |
J7509 | Methylprednisolone oral, per 4 mg |
J7510 | Prednisolone oral, per 5 mg |
J7511 | Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg |
J7512 | Prednisone, immediate release or delayed release, oral, 1 mg |
J7513 | Daclizumab, parenteral, 25 mg |
J7515 | Cyclosporine, oral, 25 mg |
J7516 | Cyclosporin, parenteral, 250 mg |
J7517 | Mycophenolate mofetil, oral, 250 mg |
J7518 | Mycophenolic acid, oral, 180 mg |
J7519 | Injection, mycophenolate mofetil, 10 mg |
J7520 | Sirolimus, oral, 1 mg |
J7525 | Tacrolimus, parenteral, 5 mg |
J7527 | Everolimus, oral, 0.25 mg |
J7599 | Immunosuppressive drug, not otherwise classified |
J7604 | Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram |
J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms |
J7607 | Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg |
J7608 | Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram |
J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
J7615 | Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg |
J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
J7622 | Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7624 | Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
J7627 | Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg |
J7628 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7629 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7631 | Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
J7632 | Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
J7633 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram |
J7634 | Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram |
J7635 | Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7636 | Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7637 | Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7638 | Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
J7640 | Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms |
J7641 | Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram |
J7642 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7643 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
J7645 | Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7647 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7648 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
J7649 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
J7650 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7657 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7658 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
J7659 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
J7660 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7665 | Mannitol, administered through an inhaler, 5 mg |
J7667 | Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams |
J7668 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams |
J7669 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
J7670 | Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
J7674 | Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg |
J7676 | Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg |
J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram |
J7680 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7681 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7682 | Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams |
J7683 | Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7684 | Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7685 | Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams |
J7686 | Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg |
J7699 | Noc drugs, inhalation solution administered through dme |
J7799 | Noc drugs, other than inhalation drugs, administered through dme |
J7999 | Compounded drug, not otherwise classified |
J8498 | Antiemetic drug, rectal/suppository, not otherwise specified |
J8499 | Prescription drug, oral, non chemotherapeutic, nos |
J8501 | Aprepitant, oral, 5 mg |
J8510 | Busulfan; oral, 2 mg |
J8515 | Cabergoline, oral, 0.25 mg |
J8520 | Capecitabine, oral, 150 mg |
J8521 | Capecitabine, oral, 500 mg |
J8530 | Cyclophosphamide; oral, 25 mg |
J8540 | Dexamethasone, oral, 0.25 mg |
J8560 | Etoposide; oral, 50 mg |
J8562 | Fludarabine phosphate, oral, 10 mg |
J8565 | Gefitinib, oral, 250 mg |
J8597 | Antiemetic drug, oral, not otherwise specified |
J8600 | Melphalan; oral, 2 mg |
J8610 | Methotrexate; oral, 2.5 mg |
J8650 | Nabilone, oral, 1 mg |
J8655 | Netupitant 300 mg and palonosetron 0.5 mg, oral |
J8670 | Rolapitant, oral, 1 mg |
J8700 | Temozolomide, oral, 5 mg |
J8705 | Topotecan, oral, 0.25 mg |
J8999 | Prescription drug, oral, chemotherapeutic, nos |
J9000 | Injection, doxorubicin hydrochloride, 10 mg |
J9010 | Injection, alemtuzumab, 10 mg |
J9015 | Injection, aldesleukin, per single use vial |
J9017 | Injection, arsenic trioxide, 1 mg |
J9019 | Injection, asparaginase (erwinaze), 1,000 iu |
J9020 | Injection, asparaginase, not otherwise specified, 10,000 units |
J9021 | Injection, asparaginase, recombinant, (rylaze), 0.1 mg |
J9022 | Injection, atezolizumab, 10 mg |
J9023 | Injection, avelumab, 10 mg |
J9025 | Injection, azacitidine, 1 mg |
J9027 | Injection, clofarabine, 1 mg |
J9029 | Injection, nadofaragene firadenovec-vncg, per therapeutic dose |
J9030 | Bcg live intravesical instillation, 1 mg |
J9031 | Bcg (intravesical) per instillation |
J9032 | Injection, belinostat, 10 mg |
J9033 | Injection, bendamustine hcl (treanda), 1 mg |
J9034 | Injection, bendamustine hcl (bendeka), 1 mg |
J9035 | Injection, bevacizumab, 10 mg |
J9036 | Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg |
J9037 | Injection, belantamab mafodotin-blmf, 0.5 mg |
J9039 | Injection, blinatumomab, 1 microgram |
J9040 | Injection, bleomycin sulfate, 15 units |
J9041 | Injection, bortezomib, 0.1 mg |
J9042 | Injection, brentuximab vedotin, 1 mg |
J9043 | Injection, cabazitaxel, 1 mg |
J9044 | Injection, bortezomib, not otherwise specified, 0.1 mg |
J9045 | Injection, carboplatin, 50 mg |
J9046 | Injection, bortezomib, (dr. reddy’s), not therapeutically equivalent to j9041, 0.1 mg |
J9047 | Injection, carfilzomib, 1 mg |
J9048 | Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg |
J9049 | Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg |
J9050 | Injection, carmustine, 100 mg |
J9051 | Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg |
J9052 | Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg New |
J9055 | Injection, cetuximab, 10 mg |
J9056 | Injection, bendamustine hydrochloride (vivimusta), 1 mg |
J9057 | Injection, copanlisib, 1 mg |
J9058 | Injection, bendamustine hydrochloride (apotex), 1 mg |
J9059 | Injection, bendamustine hydrochloride (baxter), 1 mg |
J9060 | Injection, cisplatin, powder or solution, 10 mg |
J9061 | Injection, amivantamab-vmjw, 2 mg |
J9063 | Injection, mirvetuximab soravtansine-gynx, 1 mg |
J9064 | Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg |
J9065 | Injection, cladribine, per 1 mg |
J9070 | Cyclophosphamide, 100 mg |
J9071 | Injection, cyclophosphamide, (auromedics), 5 mg |
J9072 | Injection, cyclophosphamide, (dr. reddy’s), 5 mg New |
J9098 | Injection, cytarabine liposome, 10 mg |
J9100 | Injection, cytarabine, 100 mg |
J9118 | Injection, calaspargase pegol-mknl, 10 units |
J9119 | Injection, cemiplimab-rwlc, 1 mg |
J9120 | Injection, dactinomycin, 0.5 mg |
J9130 | Dacarbazine, 100 mg |
J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj |
J9145 | Injection, daratumumab, 10 mg |
J9150 | Injection, daunorubicin, 10 mg |
J9151 | Injection, daunorubicin citrate, liposomal formulation, 10 mg |
J9153 | Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine |
J9155 | Injection, degarelix, 1 mg |
J9160 | Injection, denileukin diftitox, 300 micrograms Discontinued |
J9165 | Injection, diethylstilbestrol diphosphate, 250 mg |
J9171 | Injection, docetaxel, 1 mg |
J9172 | Injection, docetaxel (ingenus) not therapeutically equivalent to j9171, 1 mg New |
J9173 | Injection, durvalumab, 10 mg |
J9175 | Injection, elliotts’ b solution, 1 ml |
J9176 | Injection, elotuzumab, 1 mg |
J9177 | Injection, enfortumab vedotin-ejfv, 0.25 mg |
J9178 | Injection, epirubicin hcl, 2 mg |
J9179 | Injection, eribulin mesylate, 0.1 mg |
J9181 | Injection, etoposide, 10 mg |
J9185 | Injection, fludarabine phosphate, 50 mg |
J9190 | Injection, fluorouracil, 500 mg |
J9196 | Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg |
J9198 | Injection, gemcitabine hydrochloride, (infugem), 100 mg |
J9199 | Injection, gemcitabine hydrochloride (infugem), 200 mg |
J9200 | Injection, floxuridine, 500 mg |
J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
J9202 | Goserelin acetate implant, per 3.6 mg |
J9203 | Injection, gemtuzumab ozogamicin, 0.1 mg |
J9204 | Injection, mogamulizumab-kpkc, 1 mg |
J9205 | Injection, irinotecan liposome, 1 mg |
J9206 | Injection, irinotecan, 20 mg |
J9207 | Injection, ixabepilone, 1 mg |
J9208 | Injection, ifosfamide, 1 gram |
J9209 | Injection, mesna, 200 mg |
J9210 | Injection, emapalumab-lzsg, 1 mg |
J9211 | Injection, idarubicin hydrochloride, 5 mg |
J9212 | Injection, interferon alfacon-1, recombinant, 1 microgram |
J9213 | Injection, interferon, alfa-2a, recombinant, 3 million units |
J9214 | Injection, interferon, alfa-2b, recombinant, 1 million units |
J9215 | Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu |
J9216 | Injection, interferon, gamma 1-b, 3 million units |
J9217 | Leuprolide acetate (for depot suspension), 7.5 mg |
J9218 | Leuprolide acetate, per 1 mg |
J9219 | Leuprolide acetate implant, 65 mg |
J9223 | Injection, lurbinectedin, 0.1 mg |
J9225 | Histrelin implant (vantas), 50 mg |
J9226 | Histrelin implant (supprelin la), 50 mg |
J9227 | Injection, isatuximab-irfc, 10 mg |
J9228 | Injection, ipilimumab, 1 mg |
J9229 | Injection, inotuzumab ozogamicin, 0.1 mg |
J9230 | Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg |
J9245 | Injection, melphalan hydrochloride, not otherwise specified, 50 mg |
J9246 | Injection, melphalan (evomela), 1 mg |
J9247 | Injection, melphalan flufenamide, 1mg |
J9250 | Methotrexate sodium, 5 mg |
J9255 | Injection, methotrexate (accord) not therapeutically equivalent to j9250 and j9260, 50 mg New |
J9258 | Injection, paclitaxel protein-bound particles (teva) not therapeutically equivalent to j9264, 1 mg New |
J9259 | Injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg |
J9260 | Methotrexate sodium, 50 mg |
J9261 | Injection, nelarabine, 50 mgJ9262 Injection, omacetaxine mepesuccinate, 0.01 mg |
J9263 | Injection, oxaliplatin, 0.5 mg |
J9264 | Injection, paclitaxel protein-bound particles, 1 mg |
J9265 | Injection, paclitaxel, 30 mg |
J9266 | Injection, pegaspargase, per single dose vial |
J9267 | Injection, paclitaxel, 1 mg |
J9268 | Injection, pentostatin, 10 mg |
J9269 | Injection, tagraxofusp-erzs, 10 micrograms |
J9270 | Injection, plicamycin, 2.5 mg |
J9271 | Injection, pembrolizumab, 1 mg |
J9272 | Injection, dostarlimab-gxly, 10 mg |
J9273 | Injection, tisotumab vedotin-tftv, 1 mg |
J9274 | Injection, tebentafusp-tebn, 1 microgram |
J9280 | Injection, mitomycin, 5 mg |
J9281 | Mitomycin pyelocalyceal instillation, 1 mg |
J9285 | Injection, olaratumab, 10 mg |
J9286 | Injection, glofitamab-gxbm, 2.5 mg New |
J9293 | Injection, mitoxantrone hydrochloride, per 5 mg |
J9294 | Injection, pemetrexed (hospira) not therapeutically equivalent to j9305, 10 mg |
J9295 | Injection, necitumumab, 1 mg |
J9296 | Injection, pemetrexed (accord) not therapeutically equivalent to j9305, 10 mg |
J9297 | Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg |
J9298 | Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg |
J9299 | Injection, nivolumab, 1 mg |
J9300 | Injection, gemtuzumab ozogamicin, 5 mg |
J9301 | Injection, obinutuzumab, 10 mg |
J9302 | Injection, ofatumumab, 10 mg |
J9303 | Injection, panitumumab, 10 mg |
J9304 | Injection, pemetrexed (pemfexy), 10 mg |
J9305 | Injection, pemetrexed, not otherwise specified, 10 mg |
J9306 | Injection, pertuzumab, 1 mg |
J9307 | Injection, pralatrexate, 1 mg |
J9308 | Injection, ramucirumab, 5 mg |
J9309 | Injection, polatuzumab vedotin-piiq, 1 mg |
J9310 | Injection, rituximab, 100 mg |
J9311 | Injection, rituximab 10 mg and hyaluronidase |
J9312 | Injection, rituximab, 10 mg |
J9313 | Injection, moxetumomab pasudotox-tdfk, 0.01 mg |
J9314 | Injection, pemetrexed (teva) not therapeutically equivalent to j9305, 10 mg |
J9315 | Injection, romidepsin, 1 mg |
J9316 | Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg |
J9317 | Injection, sacituzumab govitecan-hziy, 2.5 mg |
J9318 | Injection, romidepsin, non-lyophilized, 0.1 mg |
J9319 | Injection, romidepsin, lyophilized, 0.1 mg |
J9320 | Injection, streptozocin, 1 gram |
J9321 | Injection, epcoritamab-bysp, 0.16 mg New |
J9322 | Injection, pemetrexed (bluepoint) not therapeutically equivalent to j9305, 10 mg |
J9323 | Injection, pemetrexed ditromethamine, 10 mg |
J9324 | Injection, pemetrexed (pemrydi rtu), 10 mg New |
J9325 | Injection, talimogene laherparepvec, per 1 million plaque forming units |
J9328 | Injection, temozolomide, 1 mg |
J9330 | Injection, temsirolimus, 1 mg |
J9331 | Injection, sirolimus protein-bound particles, 1 mg |
J9332 | Injection, efgartigimod alfa-fcab, 2mg |
J9333 | Injection, rozanolixizumab-noli, 1 mg New |
J9334 | Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc New |
J9340 | Injection, thiotepa, 15 mg |
J9345 | Injection, retifanlimab-dlwr, 1 mg |
J9347 | Injection, tremelimumab-actl, 1 mg |
J9348 | Injection, naxitamab-gqgk, 1 mg |
J9349 | Injection, tafasitamab-cxix, 2 mg |
J9350 | Injection, mosunetuzumab-axgb, 1 mg |
J9351 | Injection, topotecan, 0.1 mg |
J9352 | Injection, trabectedin, 0.1 mg |
J9353 | Injection, margetuximab-cmkb, 5 mg |
J9354 | Injection, ado-trastuzumab emtansine, 1 mg |
J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg |
J9356 | Injection, trastuzumab, 10 mg and hyaluronidase-oysk |
J9357 | Injection, valrubicin, intravesical, 200 mg |
J9358 | Injection, fam-trastuzumab deruxtecan-nxki, 1 mg |
J9359 | Injection, loncastuximab tesirine-lpyl, 0.075 mg |
J9360 | Injection, vinblastine sulfate, 1 mg |
J9370 | Vincristine sulfate, 1 mg |
J9371 | Injection, vincristine sulfate liposome, 1 mg |
J9380 | Injection, teclistamab-cqyv, 0.5 mg |
J9381 | Injection, teplizumab-mzwv, 5 mcg |
J9390 | Injection, vinorelbine tartrate, 10 mg |
J9393 | Injection, fulvestrant (teva) not therapeutically equivalent to j9395, 25 mg |
J9394 | Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg |
J9395 | Injection, fulvestrant, 25 mg |
J9400 | Injection, ziv-aflibercept, 1 mg |
J9600 | Injection, porfimer sodium, 75 mg |
J9999 | Not otherwise classified, antineoplastic drugs |
What are HCPCS J Codes?
HCPCS J-Codes are part of a standardized coding system used to identify and bill for drugs, supplies, and services. These codes are employed for documenting injectable medications typically not suitable for self-administration. This includes chemotherapy, immunosuppressive drugs, inhalation solutions, and certain orally administered medications. Moreover these codes specifically target drugs administered through routes other than oral methods, ensuring accurate reimbursement and uniform coding practices.
Drugs Administered Beyond Oral Methods
J Codes primarily cover drugs administered through various non-oral routes, including injections, infusions, and other parenteral methods. This includes medications delivered intravenously, intramuscularly, subcutaneously, and through other non-oral routes.
Emphasis on Chemotherapy Drugs
One significant subset of J-Codes focuses on chemotherapy drugs. These codes are instrumental in accurately documenting and billing for the administration of chemotherapy agents, crucial in the treatment of various cancers.
How to Assign J Codes?
Healthcare professionals must carefully select J-Codes based on specific criteria, including the drug administered, dosage, and route of administration. Additionally accurate code assignment is crucial for proper documentation and billing.
Thorough documentation of the drug administration process is essential for proper code assignment. Healthcare providers should include information on the drug name, dosage, route of administration, and any relevant patient-specific details.
Conclusion
In conclusion, chemotherapy drugs Codes is paramount for healthcare professionals seeking to navigate the intricate landscape of medical billing and coding. Navigate our guide with confidence; furthermore, Check our complete HCPCS Codes Lookup to enhance your coding proficiency. Moreover, Empower yourself and your healthcare organization with the knowledge and precision required for efficient billing, compliance, and optimal patient care.
Hi, I’m Emma Taylor! a seasoned expert in the field of medical billing & coding, bringing a wealth of knowledge and experience to the healthcare industry. With a background in healthcare administration and a passion for optimizing billing processes, I am dedicated to helping medical professionals navigate the complexities of billing and coding. Here I shares valuable insights, tips, and resources to empower healthcare practitioners with the information they need to streamline billing operations and enhance overall efficiency.